Stocks · Health care · Services-Medical Laboratories

Aclarion, Inc.

ACON Clue Score55
United States Fiscal year ends December CIK 0001635077
$2.34 +1.30% Close, 9 Oct 2026
Price $2.34 +484.56% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 22 Apr 2022. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2021Revenue0.1Operating income−3.0Net income−5.0EPS, diluted−6.58Fiscal year 2022Revenue0.1 +0.3%Operating income−5.6Net income−7.1EPS, diluted−19.61Fiscal year 2023Revenue0.1 +24.8%Operating income−4.9Net income−4.9EPS, diluted−79,782.00Fiscal year 2024Revenue0.0 −39.4%Operating income−5.5Net income−7.0EPS, diluted−7,478.90Fiscal year 2025Revenue0.1 +65.6%Operating income−7.1Net income−7.2EPS, diluted−13.61
FY2021FY2022FY2023FY2024FY2025
Revenue 0.1 0.1 0.1 0.0 0.1
Growth +0.3% +24.8% −39.4% +65.6%
Operating income −3.0 −5.6 −4.9 −5.5 −7.1
Net income −5.0 −7.1 −4.9 −7.0 −7.2
Growth
EPS, diluted −6.58 −19.61 −79,782.00 −7,478.90 −13.61

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2021Gross margin−14.7%Operating margin−4,897.9%Net margin−8,210.5%Fiscal year 2022Gross margin−8.0%Operating margin−9,201.2%Net margin−11,694.4%Fiscal year 2023Gross margin−0.4%Operating margin−6,466.5%Net margin−6,513.4%Free cash flow margin−4,836.5%Fiscal year 2024Gross margin−85.2%Operating margin−12,057.2%Net margin−15,293.8%Free cash flow margin−11,540.4%Fiscal year 2025Gross margin9.0%Operating margin−9,312.5%Net margin−9,551.9%Free cash flow margin−9,488.6%
FY2021FY2022FY2023FY2024FY2025
Gross margin −14.7% −8.0% −0.4% −85.2% 9.0%
Operating margin −4,897.9% −9,201.2% −6,466.5% −12,057.2% −9,312.5%
Net margin −8,210.5% −11,694.4% −6,513.4% −15,293.8% −9,551.9%
Free cash flow margin n/a n/a −4,836.5% −11,540.4% −9,488.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2021Operating cash flow−2.4Fiscal year 2022Operating cash flow−4.9Fiscal year 2023Operating cash flow−3.6Capital expenditure0.0Free cash flow−3.6Fiscal year 2024Operating cash flow−5.3Capital expenditure−0.0Free cash flow−5.3Fiscal year 2025Operating cash flow−7.2Capital expenditure−0.0Free cash flow−7.2
FY2021FY2022FY2023FY2024FY2025
Operating cash flow −2.4 −4.9 −3.6 −5.3 −7.2
Capital expenditure n/a n/a 0.0 −0.0 −0.0
Free cash flow n/a n/a −3.6 −5.3 −7.2
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2021Cash0.4Shareholders’ equity−12.8Fiscal year 2022Cash1.5Shareholders’ equity2.2Fiscal year 2023Cash1.0Shareholders’ equity−0.7Fiscal year 2024Cash0.5Shareholders’ equity1.0Fiscal year 2025Cash12.0Shareholders’ equity12.8
FY2021FY2022FY2023FY2024FY2025
Cash 0.4 1.5 1.0 0.5 12.0
Shareholders’ equity −12.8 2.2 −0.7 1.0 12.8

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Margins
−14.7% −8.0% −0.4% −85.2% 9.0%
−4,897.9% −9,201.2% −6,466.5% −12,057.2% −9,312.5%
n/a −11,694.4% −6,513.4% −15,293.8% −9,551.9%
−8,210.5% −11,694.4% −6,513.4% −15,293.8% −9,551.9%
n/a n/a −4,836.5% −11,540.4% −9,488.6%
Spending
1,306.7% 1,766.9% 1,158.2% 1,943.8% 1,365.1%
3,027.7% 6,602.3% 4,303.9% 7,892.6% 5,446.8%
n/a n/a 0.0% 11.2% 28.4%
Returns
n/a −317.6% n/a −720.9% −56.4%
−262.0% −242.5% −199.7% −329.3% −52.9%
Balance and payout
403.2% n/a 129.6% 54.3% 6.1%